Most cited papers from Vaxxas (Australia)

Vaxxas (Australia)

What are the most cited papers from Vaxxas (Australia)?

The most cited paper from Vaxxas (Australia) is "Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)" (Germain J. P. Fernando, Julian Hickling, Cesar M. Jayashi Flores et al., 2018), with 129 citations. Next come "Dissolvable polymer microneedles for drug delivery and diagnostics" (127) and "Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial" (102).

Published TypeFieldAccessCitations

Showing 37 of 37 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™) Germain J. P. Fernando, Julian Hickling, Cesar M. Jayashi Flores et al. · Vaccine Open access	17 May 2018	129
2	Dissolvable polymer microneedles for drug delivery and diagnostics Masood Ali, Sarika Namjoshi, Heather A. E. Benson et al. · Journal of Controlled Release	24 May 2022	127
3	Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial Angus Harry Forster, Katey L. Witham, Alexandra C. I. Depelsenaire et al. · PLoS Medicine Open access	17 Mar 2020	102
4	Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice Frances Elizabeth Pearson, Celia L. McNeilly, Michael Lawrence Crichton et al. · PLoS ONE Open access	9 Jul 2013	73
5	Transcription regulation of MYB: a potential and novel therapeutic target in cancer Partha Mitra · Annals of Translational Medicine Open access	Nov 2018	72
6	White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin Maria Dul et al. · Journal of Controlled Release Open access	20 Dec 2024	59
7	Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris et al. · Science Advances Open access	29 Oct 2021	48
8	Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects Paul Griffin, Suzanne L. Elliott, Kenia G. Krauer et al. · Vaccine Open access	23 Oct 2017	45
9	The hyperelastic and failure behaviors of skin in relation to the dynamic application of microscopic penetrators in a murine model Stefano C. Meliga, Jacob W. Coffey, Michael Lawrence Crichton et al. · Acta Biomaterialia	16 Oct 2016	43
10	High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses David Alexander Muller, Germain J. P. Fernando, Nick S. Owens et al. · Scientific Reports Open access	27 Sep 2017	40
11	Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product Maria Dul et al. · Journal of Controlled Release Open access	8 Aug 2023	38
12	A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice Jovin J. Y. Choo, Laura J. Vet, Christopher L. D. McMillan et al. · npj Vaccines Open access	7 May 2021	34
13	Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis Matthew N. Berger, Ellen S Mowbray, Marian W. A. Farag et al. · BMJ Global Health ReviewOpen access	Oct 2023	30
14	Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment Brian K. Meyer, Mark A.F. Kendall, Donna Marie Williams et al. · Vaccine X Open access	20 Jun 2019	30
15	Innate local response and tissue recovery following application of high density microarray patches to human skin David Alexander Muller, Joakim Henricson, Ben Baker et al. · Scientific Reports Open access	28 Oct 2020	26
16	Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch TM Microneedle Delivery System Ying Wan, Vineet Kumar Gupta, Chris Bird et al. · Human Vaccines & Immunotherapeutics Open access	6 May 2021	23
17	Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array Ying Wan, John Michael Hickey, Chris Bird et al. · Journal of Pharmaceutical Sciences Open access	6 Feb 2018	23
18	Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch Jovin J. Y. Choo, Christopher L. D. McMillan, Germain J. P. Fernando et al. · Vaccines Open access	9 Nov 2021	21
19	Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings Cristyn Davies, Melody Taba, Lucy Deng et al. · Human Vaccines & Immunotherapeutics Open access	31 Jan 2022	20
20	Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial Ben Baker, Imogen M. Bermingham, Indika Leelasena et al. · Vaccines Open access	17 Nov 2023	19
21	M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP) Jamie-Lee S. Mills, Cesar M. Jayashi Flores, Simone L. Reynolds et al. · npj Vaccines Open access	7 Aug 2020	19
22	Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial Alexandra C. I. Depelsenaire, Katey L. Witham, Margaret Veitch et al. · PLoS ONE Open access	30 Jul 2021	18
23	Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern Christopher L. D. McMillan, Armira Azuar, Jovin J. Y. Choo et al. · Vaccines Open access	8 Apr 2022	17
24	Evaluation of the self-administration potential of high-density microarray patches to human skin: A preliminary study Ben Baker, Elke Hacker, Greg Siller et al. · Human Vaccines & Immunotherapeutics Open access	2 Jan 2023	14
25	An Ultrahigh‐Density Microneedle Array for Skin Vaccination: Inducing Epidermal Cell Death by Increasing Microneedle Density Enhances Total IgG and IgG1 Immune Responses Jacob W. Coffey, Nicole M. D. van der Burg, Thippayawan Rananakomol et al. · Advanced NanoBiomed Research Open access	9 May 2022	14
26	Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine Danushka K. Wijesundara, Arthur Eng Lip Yeow, Christopher L. D. McMillan et al. · Molecular Therapy — Nucleic Acids Open access	16 Oct 2023	12
27	Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates Elke Hacker, Ben Baker, T. Lake et al. · Vaccine Open access	27 Aug 2023	9
28	Herpes simplex virus spreads rapidly in human foreskin, partly driven by chemokine-induced redistribution of Nectin-1 on keratinocytes Hafsa Rana, Naomi R. Truong, B. H. Johnson et al. · PLoS Pathogens Open access	10 Jun 2024	8
29	Local Response and Barrier Recovery in Elderly Skin Following the Application of High-Density Microarray Patches Fredrik Iredahl, David Alexander Muller, Totte Togö et al. · Vaccines Open access	10 Apr 2022	7
30	Micropuncture closure following high density microarray patch application in healthy subjects Joakim Henricson, David Alexander Muller, Ben Baker et al. · Skin Research and Technology Open access	22 Jan 2022	6
31	Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein Christopher L. D. McMillan, Danushka K. Wijesundara, Jovin J. Y. Choo et al. · Journal of General Virology Open access	25 Jan 2024	5
32	Vaccine microarray patch self-administration: A preliminary study in adults 50 years of age and over Cristyn Davies, Ben Baker, Matthew N. Berger et al. · Vaccine Open access	30 Jan 2025	4
33	Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses Christopher L. D. McMillan, Andrea V. Corner, Danushka K. Wijesundara et al. · Heliyon Open access	Feb 2025	2
34	Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults Christopher L. D. McMillan, David Alexander Muller, Germain J. P. Fernando et al. · Vaccines Open access	25 Dec 2025	0
35	Tracking antigen presenting cells to uncover the intrinsic immunostimulatory properties of microarray vaccine patches using a fluosphere-based assay Danushka K. Wijesundara, Alexandra Playford, Kimberley D. Bruce et al. · Vaccine X Open access	28 Oct 2025	0
36	Benefits and challenges of high-density microarray patches for vaccination among older adults: A qualitative study Matthew N. Berger, Sara L. Knox, Ben Baker et al. · Health Policy and Technology Open access	2 Jul 2025	0
37	When academia met industry: working toward a needle‐free vaccination future in the sunshine state Arti Medhavy, Alex Johnston, Imogen M. Bermingham et al. · Immunology and Cell Biology Open access	9 Nov 2024	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.